Bayer to Present Investigational Data from Comprehensive KERENDIA® (finerenone) Clinical Trial Program at Heart Failure 2024 Congress [Yahoo! Finance]
BAYER AG S/ADR (BAYRY)
NASDAQ:AMEX Investor Relations:
investor.bayer.com
Company Research
Source: Yahoo! Finance
Data examining kidney risk, markers of cardiorenal risk, and health status assessment among patients with heart failure (HF) with left ventricular ejection fraction (LVEF) =40% Data investigating the use of gamification to improve enrollment of patients in FINEARTS-HF trial WHIPPANY, N.J., May 10, 2024 BUSINESS WIRE )--Bayer will present Kerendia ® (finerenone) data from its comprehensive clinical trial program in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) in addition to data from FINEARTS-HF, the ongoing randomized, double-blind, placebo-controlled, multicenter, event-driven Phase III study is investigating the efficacy (including CV death and total HF events) and safety of finerenone compared to placebo in patients suffering from symptomatic HF with an ejection fraction of =40% (HFmrEF/HFpEF), at Heart Failure 2024, a scientific congress of the European Society of Cardiology (ESC), taking place May 11-14, 2024 in Lisbon, Portugal. Finerenone is marke
Show less
Read more
Impact Snapshot
Event Time:
BAYRY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BAYRY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BAYRY alerts
High impacting BAYER AG S/ADR news events
Weekly update
A roundup of the hottest topics
BAYRY
News
- Global Lipid Nanoparticle Raw Materials Market Size is Projected to Hit USD 333.85 million at a 5.2% CAGR from 2024 to 2032- Report by Polaris Market Research (PMR) [Yahoo! Finance]Yahoo! Finance
- Actio Biosciences Appoints Ben Cravatt, Ph.D., to Board of Directors [Yahoo! Finance]Yahoo! Finance
- Bayer is going all in to create legal shields in Missouri, Iowa and Idaho against 170,000 Roundup weedkiller lawsuits it faces [Fortune]Fortune
- Maker of popular weedkiller amplifies fight against cancer-related lawsuits [Financial Post (Toronto, Ontario, Canada)]Financial Post
- Maker of popular weedkiller amplifies fight against cancer-related lawsuits [Yahoo! Finance Canada]Yahoo! Finance Canada